期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Genetic Structure and Eco-Geographical Differentiation of Cultivated Keng Rice(Oryza sativa L.subsp.japonica) in China Revealed by Microsatellites 被引量:1
1
作者 ZHANG Dong-ling wang mei-xing +5 位作者 QIYong-wen SUN Jun-li wang Feng-mei LI Jin-jie ZHANG Hong-liang ELI Zi-chao 《Journal of Integrative Agriculture》 SCIE CAS CSCD 2012年第11期1755-1766,共12页
China is one of the largest centers of genetic diversity of Oryza sativa L. and is the original centers of Oryza sativa L. subspecies japonica. Using a genetically representative core collection of 1 442 rice landrace... China is one of the largest centers of genetic diversity of Oryza sativa L. and is the original centers of Oryza sativa L. subspecies japonica. Using a genetically representative core collection of 1 442 rice landraces of japonica in China, the genetic structure, differentiation, and geographic diversity were analyzed. The model-based structure analysis on varieties within three ecotypes revealed 16 eco-geographical types, which are partially accorded with some of the ecological zones in China. The differentiation of eco-geographical types contributed to the local ecological adaption and physical isolation, and maybe could be used to develop the heterotic groups of japonica. To facilitate the identification of different ecotypes and eco-geographical types, we provided the SSR character alleles of each ecotype or geographical eco-group and a rapid discriminated method based on these character alleles. Lastly, investigation on genetic diversity, genetic differentiation indicated that southwest region of China, including south of Yunnan Province, northwest of Guangxi Zhuang Autonomous Region, and southwest of Guizhou Province, possessed the highest genetic diversity and all the necessary conditions as a center of genetic diversity and should be the center of genetic diversity of rice landraces of japonica in China. 展开更多
关键词 japonica rice population structure eco-geographical differentiation China microsateltites
下载PDF
蒽环类药物新辅助化疗对乳腺癌患者耐药基因ERCC1表达的影响及临床意义 被引量:4
2
作者 李纲 杨梅 +4 位作者 左丽 李小静 王妹兴 党雪菲 李小丽 《中国肿瘤临床与康复》 2018年第5期537-541,共5页
目的探讨蒽环类药物新辅助化疗(NC)对乳腺癌患者耐药基因切除修复交叉互补基因1(ERCC1)表达的影响及临床意义。方法选取2015年1月至2016年12月间复旦大学附属肿瘤医院闵行分院收治的接受手术治疗的98例乳腺癌患者,按照术前是否实施蒽环... 目的探讨蒽环类药物新辅助化疗(NC)对乳腺癌患者耐药基因切除修复交叉互补基因1(ERCC1)表达的影响及临床意义。方法选取2015年1月至2016年12月间复旦大学附属肿瘤医院闵行分院收治的接受手术治疗的98例乳腺癌患者,按照术前是否实施蒽环类药物NC治疗分为观察组(50例)和对照组(48例)。观察组患者术前予以蒽环类药物NC治疗,对照组不进行NC治疗,术后对比对照组患者的病理特征与ERCC1mRNA表达水平的关系及两组患者ERCC1mRNA表达水平及阳性率,并分析观察组患者疗效及不良反应。结果对照组患者的病理特征不同,ERCC1mRNA表达水平无差异,差异无统计学意义(P>0.05)。治疗后,观察组患者总缓解率为64.0%,不良反应总发生率为68.0%。观察组患者ERCC1mRNA表达水平及阳性率明显高于对照组患者,差异均有统计学意义(均P<0.05)。结论 ERCC1表达与乳腺癌患者病理特征无明显关联,采用蒽环类药物实施NC对于乳腺癌耐药基因ERCC1的表达具有明显的提升作用,临床可考虑监测ERCC1基因表达助于评估患者病情。 展开更多
关键词 蒽环类药物 新辅助化疗 乳腺肿瘤 耐药基因 ERCC1
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部